Gattex
Drug: Gattex
Generic molecule: teduglutide
Company: NPS Pharmaceuticals
Approval date: Dec. 21
The scoop: The FDA approved NPS' Gattex, a GLP-2 drug, for treating short bowel syndrome just as the holiday exodus began. NPS prepared for the transition to the commercial realm this year; CEO Francois Nader told FierceBiotech that 2012 would be transformational for his company. The U.S. regulator's approval of the drug follows the European Commission's approval in August.
